Assays

Achieve maximum impact
in testing for SARS-CoV-2

Ability to test ample portions of the symptomatic and asymptomatic population, do contact tracing and enforce isolation of those who have been infected is key for containing the spread of SARS-CoV-21

  • The COVID-19 pandemic continues to impact Europe as countries work to manage testing and transmission control of this infectious virus
  • New! With saliva samples now approved for use on BD SARS-CoV-2 Reagents for BD MAX™ System, it offers a non-invasive alternative for COVID-19 specimen collection
  • New! Any need to detect and differentiate variants within a SARS-CoV-2 positive result? CerTest VIASURE SARS-CoV-2 Variant Real Time PCR Detection Kit for BD MAX™ can be used as a reflex test to identify the 3 variants of concern: B.1.1.7 (Alpha), B.1.351 (Beta), and P.1 (Gamma)
24 Million confirmed
~ 24 Million confirmed
 cases of COVID-19
globally in only 9 months2
827,246 deaths
~ 827,246 deaths
from COVID-19
globally in only 9 months2

Molecular testing can play an important role in controlling the SARS-CoV-2 transmission3

  • The BD SARS-CoV-2 Reagents for BD MAX™ System is a real-time RT-PCR test designed to detect SARS-CoV-2 in nasal, nasopharyngeal and oropharyngeal swabs and saliva samples for both symptomatic and asymptomatic individuals4
  • The assay utilizes multiplexed primers and probes targeting RNA from the nucleocapsid phosphoprotein gene (N1 and N2 regions) of the SARS-CoV-2 coronavirus, and the human RNase P gene4

The BD SARS-CoV-2 Reagents for BD MAX™ System is a fully integrated solution to help you achieve clinical efficiency

  • Simplified and automated workflow
  • Pre-loaded unitized reagent strips
  • Run up to 24 samples at a time
  • Results in about 2 hours
Fast time to result
Fast time
to result
Workflow efficiency
Workflow
efficiency
Supports patient management
Supports patient
management

The BD SARS-CoV-2 assay is fully integrated
on the BD MAX™ System

Discover BD’s full Respiratory Infections Portfolio

COVID-19, coronavirus disease 2019; PCR, polymerase chain reaction; RT-PCR, real time polymerase chain reaction; SARS-CoV-2, severe acute respiratory syndrome coronavirus 2.

1. European Data Portal. Widespread Testing: Differing Strategies across Europe. Accessed September 2, 2020. Available from: https://www.europeandataportal.eu/en/impact-studies/covid-19/widespread-testing-differing-strategies-across-Europe.  2. World Health Organization. WHO coronavirus disease (COVID-19) dashboard. Cumulative data of global confirmed cases. World Health Organization website. Accessed August 28, 2020. Available from: https://covid19.who.int. 3. Grassly NC et al. Lancet Infect Dis. 2020. doi: 10.1016/S1473-3099(20)30630-7. Online ahead of print. 4. BD SARS-CoV-2 Reagents for BD MAX™ System IFU, P0255(03). Updated August 2020.